Jaguar Health Inc
(JAGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 5,775 | 4,416 | 4,361 | 142 | 258 |
| Cost of Goods | 3,816 | 2,766 | 880 | 52 | 124 |
| Gross Profit | 1,959 | 1,650 | 3,481 | 90 | 135 |
| Operating Expenses | 31,723 | 33,240 | 38,608 | 13,728 | 12,704 |
| Operating Income | -28,948 | -30,824 | -34,247 | -13,586 | -12,445 |
| Interest Expense | 5,731 | 2,629 | 1,210 | 986 | 3,317 |
| Other Income | -3,850 | 1,307 | 307 | -162 | -529 |
| Pre-tax Income | -38,529 | -32,146 | -35,150 | -14,734 | -16,292 |
| Income Tax | 10 | N/A | -13,181 | 0 | N/A |
| Net Income Continuous | -38,539 | -32,146 | -21,969 | -14,734 | -16,292 |
| Net Income | $-38,539 | $-32,146 | $-21,969 | $-14,734 | $-16,292 |
| EPS Basic Total Ops | -9.01 | -153.27 | -7.59 | -1.35 | -2.70 |
| EPS Basic Continuous Ops | -7.76 | -153.27 | -7.59 | -1.35 | -2.65 |
| EPS Diluted Total Ops | -9.01 | -153.27 | -7.59 | -1.35 | -2.70 |
| EPS Diluted Continuous Ops | -7.76 | -153.27 | -7.59 | -1.35 | -2.65 |
| EBITDA(a) | $-21,863 | $-23,097 | $-16,235 | $-13,028 | $-9,720 |